Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients

Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients

Diabetic kidney disease (DKD) can lead to end-stage kidney disease (ESKD) and mortality; however, few mechanistic biomarkers are available for high-risk patients, especially those without macroalbuminuria. Urine from participants with diabetes from the Chronic Renal Insufficiency Cohort (CRIC) study...

Full description

Bibliographic Details
Main Authors:	Kumar Sharma, Guanshi Zhang, Jens Hansen, Petter Bjornstad, Hak Joo Lee, Rajasree Menon, Leila Hejazi, Jian-Jun Liu, Anthony Franzone, Helen C. Looker, Byeong Yeob Choi, Roman Fernandez, Manjeri A. Venkatachalam, Luxcia Kugathasan, Vikas S. Sridhar, Loki Natarajan, Jing Zhang, Varun S. Sharma, Brian Kwan, Sushrut S. Waikar, Jonathan Himmelfarb, Katherine R. Tuttle, Bryan Kestenbaum, Tobias Fuhrer, Harold I. Feldman, Ian H. de Boer, Fabio C. Tucci, John Sedor, Hiddo Lambers Heerspink, Jennifer Schaub, Edgar A. Otto, Jeffrey B. Hodgin, Matthias Kretzler, Christopher R. Anderton, Theodore Alexandrov, David Cherney, Su Chi Lim, Robert G. Nelson, Jonathan Gelfond, Ravi Iyengar, for the Kidney Precision Medicine Project
Format:	Article
Language:	English
Published:	American Society for Clinical Investigation 2023-10-01
Series:	The Journal of Clinical Investigation
Subjects:	Nephrology
Online Access:	https://doi.org/10.1172/JCI170341

Similar Items

Endogenous adenine mediates kidney injury in diabetic models and predicts diabetic kidney disease in patients
by: Sharma, Kumar, et al.
Published: (2024)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
by: Daniel H. Van Raalte, et al.
Published: (2022-05-01)

Glycolytic lactate in diabetic kidney disease
by: Darshi, Manjula, et al.
Published: (2024)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
by: Priya Vart, et al.
Published: (2022-09-01)

Dietary Oxalate Intake and Kidney Outcomes
by: Matteo Bargagli, et al.
Published: (2020-09-01)

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models.
by: Jan A J G van den Brand, et al.
Published: (2019-01-01)

Needle Size and the Risk of Kidney Biopsy Bleeding Complications
by: Salena Cui, et al.
Published: (2016-11-01)

Advances in understanding ischemic acute kidney injury
by: Himmelfarb Jonathan, et al.
Published: (2011-02-01)

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
by: J. David Smeijer, et al.
Published: (2023-09-01)

Nephrologists’ Attitudes Toward Native Kidney Biopsy: A Qualitative Study
by: Afolarin Amodu, et al.
Published: (2021-11-01)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?
by: Paul Perco, et al.
Published: (2019-02-01)

Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis
by: Hongtao Yu, et al.
Published: (2024-04-01)

Assessment of kidney proximal tubular secretion in critical illness
by: Pavan K. Bhatraju, et al.
Published: (2021-05-01)

Kidney Disease–Related Mortality Among Asian Americans
by: Sophie E. Claudel, MD, et al.
Published: (2023-08-01)

Obesity-Related Kidney Disease: Current Understanding and Future Perspectives
by: Frederik F. Kreiner, et al.
Published: (2023-09-01)

Machine Learning Applications in Nephrology: A Bibliometric Analysis Comparing Kidney Studies to Other Medicine SubspecialitiesPlain-Language Summary
by: Ashish Verma, et al.
Published: (2021-09-01)

The geographical distribution of leadership in globalized clinical trials.
by: Jarno Hoekman, et al.
Published: (2012-01-01)

Bleeding Complications After Percutaneous Native Kidney Biopsy: Results From the Boston Kidney Biopsy Cohort
by: Ragnar Palsson, et al.
Published: (2020-04-01)

Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
by: Sok Cin Tye, et al.
Published: (2022-01-01)

Multimodal single cell sequencing implicates chromatin accessibility and genetic background in diabetic kidney disease progression
by: Parker C. Wilson, et al.
Published: (2022-09-01)

Single cell transcriptional and chromatin accessibility profiling redefine cellular heterogeneity in the adult human kidney
by: Yoshiharu Muto, et al.
Published: (2021-04-01)

Outcome of critically ill patients with acute kidney injury using the akin criteria
by: Mandelbaum, Tal, et al.
Published: (2012)

The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.
by: Bauke Schievink, et al.
Published: (2014-01-01)

Urinary Biomarkers and Kidney Outcomes: Impact of Indexing Versus Adjusting for Urinary CreatininePlain-Language Summary
by: Nicholas Wettersten, et al.
Published: (2021-07-01)

SODIUM INTAKE AND RISK OF CORONARY HEART DISEASE IN THE OVERALL POPULATION AND SPECIFIC SUBPOPULATIONS
by: Michel Joosten, et al.
Published: (2012-06-01)

Acknowledgment to the Reviewers of <i>Kidney and Dialysis</i> in 2022
by: Kidney and Dialysis Editorial Office
Published: (2023-01-01)

Indirect Insulin Resistance Indices and Their Cut-Off Values for the Prediction of Post-Transplantation Diabetes Mellitus in Kidney Transplant Recipients
by: Sara Sokooti, et al.
Published: (2023-11-01)

Physician Attitudes on Kidney Biopsies for Research: A Survey Study
by: Gearoid M. McMahon, MB BCh, et al.
Published: (2020-01-01)

Initiation of the SGLT2 inhibitor canagliflozin to prevent kidney and heart failure outcomes guided by HbA1c, albuminuria, and predicted risk of kidney failure
by: Sok Cin Tye, et al.
Published: (2022-09-01)

How to measure and monitor albuminuria in healthy toddlers?
by: Sophie Marielle van den Belt, et al.
Published: (2018-01-01)

Uric Acid and Acute Kidney Injury in the Critically Ill
by: Anand Srivastava, et al.
Published: (2019-01-01)

Cross-validation of SARS-CoV-2 responses in kidney organoids and clinical populations
by: Louisa Helms, et al.
Published: (2021-12-01)

Renal end points in clinical trials of kidney disease
by: Weldegiorgis, M, et al.
Published: (2015)

The chromatin landscape of healthy and injured cell types in the human kidney
by: Debora L. Gisch, et al.
Published: (2024-01-01)

Chronic kidney disease in disadvantaged populations
by: Guillermo Garcia-Garcia, et al.
Published: (2015-01-01)

Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus
by: Meghan E. Sise, et al.
Published: (2020-08-01)

l‐Homoarginine supplementation prevents diabetic kidney damage
by: Michael D. Wetzel, et al.
Published: (2019-09-01)

Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes
by: El-Meanawy Ashraf, et al.
Published: (2012-07-01)

Translational Assessment of Drug‐Induced Proximal Tubule Injury Using a Kidney Microphysiological System
by: Maass, Christian, et al.
Published: (2022)

Translational Assessment of Drug‐Induced Proximal Tubule Injury Using a Kidney Microphysiological System
by: Christian Maass, et al.
Published: (2019-05-01)